// February 04, 2020
Strengthening Biotherapeutic Innovations through Emerging Analytical Tools
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr
By the year 2020, biopharmaceuticals are estimated to account for 50% of the most successful phar
Highly complex biologics such as proteins, monoclonal antibodies, and cell and gene therapies inc
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis